SBC Medical Group Holdings (SBC) Earnings Analysis

SBC Medical Group Holdings (SBC) next reports earnings on 2026-08-12, consensus EPS 0.12 USD. Last quarter (2026-05-14) it beat with EPS 0.11 USD vs 0.1 USD est (+10%). It has beaten estimates in 3/5 recent quarters (60%). Trailing P/E 7.44.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does SBC next report earnings?

Next earnings date2026-08-12
Consensus EPS estimate0.12 USD
Revenue estimate0.05B

SBC earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-140.11 USD0.1 USD+10%Beat
2026-03-270.14 USD0.13 USD+7.7%Beat
2025-11-140.12 USD0.13 USD-7.7%Miss
2025-08-130.02 USD0.14 USD-85.7%Miss
2025-05-150.21 USD0.11 USD+90.9%Beat

Beat rate: 3/5 (60%) over reported quarters with consensus data.

SBC valuation and analyst view

Trailing P/E7.44
Trailing EPS0.39766 USD
Price / book1.18
Dividend yield0.00%
Market cap0.30B
Analyst consensusBuy (1 buy / 0 hold / 0 sell)
Avg price target9 USD

Related research pages

Frequently asked questions

When is SBC Medical Group Holdings (SBC)'s next earnings date?

SBC Medical Group Holdings is next scheduled to report on 2026-08-12, with a consensus EPS estimate of 0.12 USD and revenue estimate of 0.05B.

Did SBC beat earnings last quarter?

In its 2026-05-14 report, SBC posted EPS of 0.11 USD versus a 0.1 USD estimate — a beat of 10%.

What is SBC's earnings track record?

Over the last 5 reported quarters with consensus data, SBC beat estimates 3 times (60%).

What is SBC's current P/E ratio and EPS?

SBC trades at a trailing P/E of 7.44 on trailing EPS of 0.39766478515547105 USD.

What do analysts rate SBC?

Analyst consensus is "Buy" across 1 ratings (0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 9 USD.